These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7566165)

  • 21. Immune privilege or inflammation? The paradoxical effects of Fas ligand.
    O'Connell J
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):73-9. PubMed ID: 10807046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
    Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
    Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 26. Fas-mediated cytotoxicity by gammadelta T cells during acute rejection in xenotransplantation of spheroidal aggregate-cultured hepatocytes.
    Ota K; Yagi T; Iwagaki H; Morimoto Y; Sadamori H; Inagaki M; Urushihara N; Matsuno T; Saito S; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):43-54. PubMed ID: 10850368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts.
    Carstens J; Markussen N; Madsen M
    Transplant Proc; 2005 Oct; 37(8):3294-7. PubMed ID: 16298578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications.
    Strand S; Galle PR
    Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A strategy for inducing immune tolerance to valve endothelial cells through gene transfer.
    Li Y; McCormack AM; Brand NJ; Yacoub MH
    J Heart Valve Dis; 2000 May; 9(3):439-44. PubMed ID: 10888103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
    Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
    Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
    Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
    Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebral xenografts: Sertoli cells to the rescue?
    Senut MC; Suhr ST; Gage FH
    Nat Biotechnol; 1996 Dec; 14(13):1650-1. PubMed ID: 9634841
    [No Abstract]   [Full Text] [Related]  

  • 33. Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?
    Allison J; Seino K; Yagita H
    Springer Semin Immunopathol; 1998; 19(3):311-22. PubMed ID: 9540159
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295
    [No Abstract]   [Full Text] [Related]  

  • 35. The cellular rejection of xenografts--recent insights.
    Sebille F; Dorling A; Lechler RI
    Xenotransplantation; 2003 Jan; 10(1):4-6. PubMed ID: 12535219
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunology. Ways around rejection.
    Vaux DL
    Nature; 1998 Jul; 394(6689):133. PubMed ID: 9687260
    [No Abstract]   [Full Text] [Related]  

  • 37. A role for CD95 ligand in preventing graft rejection.
    Bellgrau D; Gold D; Selawry H; Moore J; Franzusoff A; Duke RC
    Nature; 1995 Oct; 377(6550):630-2. PubMed ID: 7566174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture.
    Matosin N; Frank E; Engel M; Lum JS; Newell KA
    Dis Model Mech; 2014 Feb; 7(2):171-3. PubMed ID: 24713271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of reactive oxygen species generation in rabbit corneal epithelial cells on inflammatory and apoptotic signaling pathways in the presence of high osmotic pressure.
    Chen Y; Li M; Li B; Wang W; Lin A; Sheng M
    PLoS One; 2013; 8(8):e72900. PubMed ID: 23977369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.
    Guillen-Ahlers H; Suckow MA; Castellino FJ; Ploplis VA
    PLoS One; 2010 Feb; 5(2):e9070. PubMed ID: 20140201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.